Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

This Multiple Myeloma Awareness Month, Dr Brid Seoighe, medical director at Johnson & Johnson Innovative Medicine Ireland, ...

Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of ...

Multiple myeloma is a blood cancer affecting plasma cells, causing abnormal antibody production and bone damage. Diagnosis involves blood tests, bone marrow biopsy, imaging, and genetic analysis to ...

In a recent discussion with CURE, Wrice noted that a "fear of talking to doctors" often prevents patients from sharing their full experience. She observed that younger patients, in particular, may ...

Most patients present with asymptomatic, early disease but are found to have abnormal blood and/or urine tests that lead to the diagnosis. In asymptomatic patients, laboratory findings, including ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...